Literature DB >> 20701468

Does C-reactive protein predict recurrent preeclampsia?

Hilary S Gammill1, Robert W Powers, Rebecca G Clifton, J Peter Van Dorsten, Mark A Klebanoff, Marshall D Lindheimer, Baha Sibai, Mark B Landon, Menachem Miodovnik, Mitchell Dombrowski.   

Abstract

OBJECTIVE: Evaluate association of the inflammatory marker C-reactive protein with recurrent preeclampsia.
METHODS: Serum samples collected longitudinally in women with previous preeclampsia from the Maternal-Fetal Medicine Units Network trial of aspirin to prevent preeclampsia were assayed for CRP.
RESULTS: Of 255 women studied, 50 developed recurrence. Baseline C-reactive protein concentration was similar between women who did and did not recur. After adjusting for confounders, neither elevated baseline C-reactive protein nor its change over gestation was associated with recurrence.
CONCLUSION: In this group of women with previous preeclampsia, neither baseline C-reactive protein concentration nor change in concentration over gestation was associated with recurrent preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20701468      PMCID: PMC3339658          DOI: 10.3109/10641950903214633

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  41 in total

1.  Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.

Authors:  Makrina D Savvidou; Christoph C Lees; Mauro Parra; Aroon D Hingorani; Kypros H Nicolaides
Journal:  BJOG       Date:  2002-03       Impact factor: 6.531

2.  Distribution of C-reactive protein values in the United States.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

3.  C-reactive protein during normal pregnancy and preeclampsia.

Authors:  E Teran; C Escudero; A Calle
Journal:  Int J Gynaecol Obstet       Date:  2005-06       Impact factor: 3.561

4.  Preeclampsia: an endothelial cell disorder.

Authors:  J M Roberts; R N Taylor; T J Musci; G M Rodgers; C A Hubel; M K McLaughlin
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

5.  Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

Authors:  V Mohamed-Ali; S Goodrick; A Rawesh; D R Katz; J M Miles; J S Yudkin; S Klein; S W Coppack
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

6.  Long-term mortality after preeclampsia.

Authors:  Edmund F Funai; Yechiel Friedlander; Ora Paltiel; Efrat Tiram; Xiaonan Xue; Lisa Deutsch; Susan Harlap
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

Review 7.  Preeclampsia: recent insights.

Authors:  James M Roberts; Hilary S Gammill
Journal:  Hypertension       Date:  2005-10-17       Impact factor: 10.190

8.  A history of preeclampsia identifies women who have underlying cardiovascular risk factors.

Authors:  Graeme N Smith; Mark C Walker; Aizhong Liu; Shi Wu Wen; Melissa Swansburg; Heather Ramshaw; Ruth Rennicks White; Michelle Roddy; Michelle Hladunewich
Journal:  Am J Obstet Gynecol       Date:  2008-08-08       Impact factor: 8.661

9.  Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.

Authors:  M L Tjoa; J M G van Vugt; A T J J Go; M A Blankenstein; C B M Oudejans; I J van Wijk
Journal:  J Reprod Immunol       Date:  2003-06       Impact factor: 4.054

10.  A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia.

Authors:  Chunfang Qiu; David A Luthy; Cuilin Zhang; Scott W Walsh; Wendy M Leisenring; Michelle A Williams
Journal:  Am J Hypertens       Date:  2004-02       Impact factor: 2.689

View more
  4 in total

1.  Plasma C-Reactive Protein and Pentraxin-3 Reference Intervals During Normal Pregnancy.

Authors:  Lina Wirestam; Sofia Pihl; Muna Saleh; Jonas Wetterö; Christopher Sjöwall
Journal:  Front Immunol       Date:  2021-08-02       Impact factor: 7.561

2.  Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth.

Authors:  Sofie Haedersdal; Jannie D Salvig; Martine Aabye; Christian W Thorball; Morten Ruhwald; Steen Ladelund; Jesper Eugen-Olsen; Niels J Secher
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 3.  Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?

Authors:  Janet W Rich-Edwards; Abigail Fraser; Deborah A Lawlor; Janet M Catov
Journal:  Epidemiol Rev       Date:  2013-09-11       Impact factor: 6.222

4.  Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population.

Authors:  Lyle G Best; Richa Saxena; Cindy M Anderson; Michael R Barnes; Hakon Hakonarson; Gilbert Falcon; Candelaria Martin; Berta Almoguera Castillo; Ananth Karumanchi; Kylie Keplin; Nichole Pearson; Felicia Lamb; Shellee Bercier; Brendan J Keating
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.